Both in Pharmaceuticals
AbCellera Biologics vs Parabilis Medicines
Over the past year ABCL returned +8.4% and PBLS returned −38.3%; their daily moves had a correlation of 0.53.
ABCL +8.4% PBLS −38.3%Growth of $1, one year, split-adjusted
| Metric | ABCL | PBLS |
|---|---|---|
| Price | $11.80 | $22.75 |
| Market cap | $3.82B | $2.81B |
| Today | −6.94% | −9.65% |
| 1 month | −7.3% | −44.3% |
| 6 months | +194.3% | — |
| Year to date | +245.0% | — |
| 1 year | +93.4% | — |
| Revenue growth (YoY) | −76.3% | — |
| Gross margin | 100.0% | 100.0% |
| Net margin | −1368.6% | −45239.9% |
| P/E (TTM) | — | — |
| Price / sales | 57.8× | — |
| Net cash | $540.1M | $1.11B |
| Dividend yield | — | — |
| Volatility (60d) | 93.8% | — |
| Short % of float | 15.3% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).